Jill Mhyre
Concepts (327)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesia, Obstetrical | 24 | 2025 | 40 | 6.950 |
Why?
| | Cesarean Section | 16 | 2021 | 158 | 3.390 |
Why?
| | Analgesia, Obstetrical | 12 | 2023 | 26 | 3.210 |
Why?
| | Pregnancy | 67 | 2025 | 2610 | 3.100 |
Why?
| | Anesthesia, Epidural | 8 | 2023 | 26 | 2.620 |
Why?
| | Analgesia, Epidural | 11 | 2021 | 28 | 2.370 |
Why?
| | Heart Arrest | 12 | 2025 | 144 | 2.340 |
Why?
| | Delivery, Obstetric | 11 | 2018 | 109 | 2.230 |
Why?
| | Anesthesiology | 7 | 2019 | 37 | 2.130 |
Why?
| | Labor, Obstetric | 7 | 2023 | 38 | 1.950 |
Why?
| | Postpartum Hemorrhage | 6 | 2022 | 38 | 1.880 |
Why?
| | Obstetrics | 7 | 2019 | 87 | 1.540 |
Why?
| | Maternal Mortality | 7 | 2017 | 28 | 1.510 |
Why?
| | Pregnancy Complications | 11 | 2018 | 406 | 1.440 |
Why?
| | Anesthesia | 5 | 2019 | 67 | 1.400 |
Why?
| | Patient Safety | 4 | 2018 | 103 | 1.330 |
Why?
| | Female | 74 | 2026 | 28792 | 1.330 |
Why?
| | Labor Pain | 3 | 2016 | 3 | 1.220 |
Why?
| | Cardiopulmonary Resuscitation | 8 | 2021 | 136 | 1.170 |
Why?
| | Anesthetics, Local | 5 | 2022 | 77 | 1.150 |
Why?
| | Humans | 86 | 2026 | 53246 | 1.150 |
Why?
| | Lidocaine | 2 | 2021 | 46 | 1.020 |
Why?
| | Pregnancy Complications, Cardiovascular | 6 | 2025 | 31 | 0.980 |
Why?
| | Early Diagnosis | 3 | 2015 | 84 | 0.950 |
Why?
| | Physician's Role | 2 | 2017 | 49 | 0.940 |
Why?
| | Anesthesia, General | 5 | 2019 | 99 | 0.910 |
Why?
| | Prenatal Care | 4 | 2018 | 111 | 0.870 |
Why?
| | Maternal Welfare | 2 | 2015 | 8 | 0.870 |
Why?
| | Preventive Medicine | 2 | 2015 | 23 | 0.860 |
Why?
| | Postpartum Period | 6 | 2020 | 111 | 0.850 |
Why?
| | Intubation, Intratracheal | 5 | 2017 | 116 | 0.830 |
Why?
| | Perioperative Care | 3 | 2026 | 44 | 0.760 |
Why?
| | Hemostatics | 1 | 2022 | 17 | 0.740 |
Why?
| | Fentanyl | 3 | 2022 | 40 | 0.740 |
Why?
| | Procaine | 2 | 2022 | 10 | 0.710 |
Why?
| | Developing Countries | 2 | 2020 | 66 | 0.710 |
Why?
| | Social Justice | 1 | 2022 | 34 | 0.710 |
Why?
| | Analgesics, Opioid | 4 | 2021 | 622 | 0.700 |
Why?
| | Pain Measurement | 4 | 2016 | 259 | 0.680 |
Why?
| | Hospitalization | 4 | 2014 | 749 | 0.670 |
Why?
| | Adult | 31 | 2026 | 14541 | 0.670 |
Why?
| | Sodium Bicarbonate | 1 | 2021 | 9 | 0.670 |
Why?
| | Hydromorphone | 2 | 2013 | 16 | 0.660 |
Why?
| | Patient Care Team | 4 | 2017 | 278 | 0.660 |
Why?
| | Racism | 1 | 2022 | 61 | 0.660 |
Why?
| | Epinephrine | 1 | 2021 | 92 | 0.640 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 177 | 0.640 |
Why?
| | United States | 22 | 2026 | 5413 | 0.630 |
Why?
| | Coronavirus Infections | 2 | 2020 | 188 | 0.630 |
Why?
| | Perinatology | 3 | 2018 | 3 | 0.610 |
Why?
| | Patient Simulation | 1 | 2020 | 38 | 0.610 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2022 | 305 | 0.610 |
Why?
| | Peripartum Period | 6 | 2025 | 16 | 0.610 |
Why?
| | Patient Transfer | 2 | 2020 | 99 | 0.600 |
Why?
| | Birth Certificates | 1 | 2019 | 26 | 0.590 |
Why?
| | Consensus | 4 | 2018 | 206 | 0.580 |
Why?
| | Physicians | 1 | 2022 | 242 | 0.570 |
Why?
| | Blood Transfusion | 2 | 2018 | 127 | 0.510 |
Why?
| | Nerve Block | 3 | 2012 | 42 | 0.500 |
Why?
| | Hospital Mortality | 5 | 2018 | 457 | 0.490 |
Why?
| | Mothers | 1 | 2019 | 269 | 0.490 |
Why?
| | Pandemics | 2 | 2020 | 595 | 0.480 |
Why?
| | Clinical Competence | 2 | 2020 | 406 | 0.470 |
Why?
| | Emergency Medical Services | 3 | 2015 | 122 | 0.460 |
Why?
| | Early Medical Intervention | 2 | 2015 | 13 | 0.450 |
Why?
| | Electric Countershock | 5 | 2021 | 30 | 0.450 |
Why?
| | Apgar Score | 1 | 2015 | 26 | 0.450 |
Why?
| | Catheterization | 3 | 2012 | 95 | 0.440 |
Why?
| | Health Status Indicators | 1 | 2015 | 80 | 0.430 |
Why?
| | Anticoagulants | 1 | 2018 | 280 | 0.430 |
Why?
| | Bupivacaine | 2 | 2022 | 29 | 0.430 |
Why?
| | Postanesthesia Nursing | 1 | 2014 | 9 | 0.430 |
Why?
| | Nursing Staff | 1 | 2014 | 16 | 0.430 |
Why?
| | Maternal Death | 1 | 2014 | 7 | 0.420 |
Why?
| | Healthcare Disparities | 4 | 2018 | 312 | 0.420 |
Why?
| | Sepsis | 3 | 2014 | 240 | 0.420 |
Why?
| | Risk Factors | 11 | 2025 | 4018 | 0.420 |
Why?
| | Airway Management | 4 | 2015 | 17 | 0.410 |
Why?
| | Poverty | 1 | 2016 | 233 | 0.410 |
Why?
| | Severity of Illness Index | 3 | 2013 | 1049 | 0.400 |
Why?
| | Time-to-Treatment | 1 | 2014 | 81 | 0.390 |
Why?
| | Health Status | 1 | 2015 | 306 | 0.390 |
Why?
| | Puerperal Disorders | 2 | 2013 | 22 | 0.360 |
Why?
| | Quality of Health Care | 2 | 2010 | 189 | 0.350 |
Why?
| | Health Care Surveys | 3 | 2012 | 182 | 0.340 |
Why?
| | Young Adult | 11 | 2025 | 4514 | 0.340 |
Why?
| | Population Surveillance | 2 | 2014 | 164 | 0.340 |
Why?
| | Anticipation, Psychological | 1 | 2011 | 3 | 0.340 |
Why?
| | Recovery Room | 2 | 2013 | 6 | 0.320 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2012 | 168 | 0.320 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2012 | 213 | 0.310 |
Why?
| | Intraoperative Complications | 1 | 2010 | 114 | 0.290 |
Why?
| | Medication Errors | 1 | 2009 | 24 | 0.290 |
Why?
| | Time Factors | 5 | 2021 | 2992 | 0.290 |
Why?
| | Stents | 1 | 2012 | 376 | 0.290 |
Why?
| | Clinical Protocols | 4 | 2017 | 109 | 0.280 |
Why?
| | Faculty, Medical | 1 | 2009 | 92 | 0.280 |
Why?
| | Lumbar Vertebrae | 1 | 2009 | 101 | 0.270 |
Why?
| | Myocardial Infarction | 1 | 2012 | 445 | 0.270 |
Why?
| | Hysterectomy | 4 | 2018 | 91 | 0.270 |
Why?
| | Cross-Sectional Studies | 7 | 2026 | 1723 | 0.270 |
Why?
| | Qualitative Research | 1 | 2010 | 384 | 0.260 |
Why?
| | Carotid Artery, Internal, Dissection | 1 | 2007 | 8 | 0.260 |
Why?
| | Comorbidity | 6 | 2018 | 638 | 0.250 |
Why?
| | Headache | 1 | 2007 | 75 | 0.250 |
Why?
| | Risk Assessment | 5 | 2014 | 1368 | 0.250 |
Why?
| | Obesity, Morbid | 1 | 2007 | 86 | 0.230 |
Why?
| | Antibiotic Prophylaxis | 1 | 2026 | 65 | 0.230 |
Why?
| | Equipment Design | 2 | 2021 | 290 | 0.230 |
Why?
| | Surgical Wound Infection | 1 | 2026 | 118 | 0.220 |
Why?
| | Neuromuscular Blockade | 1 | 2025 | 14 | 0.220 |
Why?
| | Income | 2 | 2016 | 106 | 0.210 |
Why?
| | Guideline Adherence | 1 | 2026 | 143 | 0.210 |
Why?
| | Disease Management | 1 | 2025 | 187 | 0.210 |
Why?
| | Treatment Outcome | 9 | 2021 | 5597 | 0.210 |
Why?
| | Renal Insufficiency | 1 | 2025 | 108 | 0.210 |
Why?
| | Attitude of Health Personnel | 1 | 2007 | 371 | 0.210 |
Why?
| | Infant, Newborn | 5 | 2020 | 2913 | 0.200 |
Why?
| | Cause of Death | 2 | 2017 | 156 | 0.200 |
Why?
| | Punctures | 1 | 2023 | 52 | 0.200 |
Why?
| | Retrospective Studies | 6 | 2025 | 6821 | 0.190 |
Why?
| | Risk | 3 | 2012 | 306 | 0.190 |
Why?
| | Cerclage, Cervical | 1 | 2022 | 8 | 0.180 |
Why?
| | Minority Groups | 2 | 2014 | 136 | 0.180 |
Why?
| | Anesthesia, Spinal | 1 | 2022 | 17 | 0.180 |
Why?
| | Communication | 2 | 2016 | 263 | 0.180 |
Why?
| | Cultural Diversity | 1 | 2022 | 37 | 0.180 |
Why?
| | Self Concept | 1 | 2022 | 65 | 0.180 |
Why?
| | Pliability | 1 | 2021 | 2 | 0.170 |
Why?
| | Prospective Studies | 5 | 2022 | 2412 | 0.170 |
Why?
| | Anxiety Disorders | 1 | 2022 | 133 | 0.170 |
Why?
| | Cohort Studies | 6 | 2025 | 1557 | 0.170 |
Why?
| | Catheters | 1 | 2021 | 34 | 0.170 |
Why?
| | Sensory Thresholds | 1 | 2021 | 15 | 0.170 |
Why?
| | Touch | 1 | 2021 | 23 | 0.170 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2021 | 28 | 0.170 |
Why?
| | Patient Discharge | 2 | 2016 | 325 | 0.160 |
Why?
| | Logistic Models | 3 | 2013 | 947 | 0.160 |
Why?
| | Analgesics | 1 | 2021 | 104 | 0.160 |
Why?
| | France | 1 | 2020 | 11 | 0.160 |
Why?
| | Monitoring, Intraoperative | 2 | 2010 | 51 | 0.150 |
Why?
| | Feedback | 1 | 2020 | 53 | 0.150 |
Why?
| | Anti-Bacterial Agents | 1 | 2026 | 832 | 0.150 |
Why?
| | Respiratory Insufficiency | 2 | 2018 | 119 | 0.150 |
Why?
| | Postoperative Complications | 4 | 2018 | 1099 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 83 | 0.140 |
Why?
| | Obesity | 1 | 2007 | 1205 | 0.140 |
Why?
| | Inpatients | 1 | 2020 | 208 | 0.140 |
Why?
| | Heroin | 1 | 2018 | 16 | 0.140 |
Why?
| | Morbidity | 2 | 2016 | 132 | 0.140 |
Why?
| | Morphine | 1 | 2018 | 103 | 0.140 |
Why?
| | Perinatal Care | 1 | 2018 | 28 | 0.130 |
Why?
| | Safety Management | 1 | 2018 | 36 | 0.130 |
Why?
| | Hospitals | 2 | 2021 | 181 | 0.130 |
Why?
| | Anesthetics | 1 | 2018 | 38 | 0.130 |
Why?
| | Posture | 2 | 2009 | 65 | 0.130 |
Why?
| | Maternal Health Services | 1 | 2018 | 34 | 0.130 |
Why?
| | Critical Care | 3 | 2020 | 215 | 0.130 |
Why?
| | Cesarean Section, Repeat | 1 | 2017 | 5 | 0.130 |
Why?
| | Fetal Death | 2 | 2015 | 22 | 0.130 |
Why?
| | Balloon Occlusion | 1 | 2017 | 17 | 0.130 |
Why?
| | Iliac Artery | 1 | 2017 | 31 | 0.130 |
Why?
| | Incidence | 2 | 2018 | 1085 | 0.130 |
Why?
| | Michigan | 3 | 2016 | 26 | 0.130 |
Why?
| | Double-Blind Method | 2 | 2022 | 729 | 0.130 |
Why?
| | Placenta Accreta | 1 | 2017 | 25 | 0.130 |
Why?
| | Laryngoscopy | 1 | 2017 | 60 | 0.130 |
Why?
| | Uterine Inertia | 2 | 2013 | 2 | 0.120 |
Why?
| | History, 21st Century | 1 | 2017 | 60 | 0.120 |
Why?
| | Causality | 2 | 2014 | 53 | 0.120 |
Why?
| | Perioperative Period | 2 | 2013 | 21 | 0.120 |
Why?
| | Registries | 4 | 2025 | 652 | 0.120 |
Why?
| | History, 20th Century | 1 | 2017 | 97 | 0.120 |
Why?
| | Case-Control Studies | 1 | 2020 | 1212 | 0.120 |
Why?
| | Fat Emulsions, Intravenous | 2 | 2014 | 12 | 0.120 |
Why?
| | Hysterotomy | 1 | 2016 | 1 | 0.120 |
Why?
| | Medical Records | 1 | 2016 | 85 | 0.120 |
Why?
| | International Classification of Diseases | 1 | 2016 | 70 | 0.120 |
Why?
| | Developed Countries | 1 | 2016 | 17 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2009 | 630 | 0.120 |
Why?
| | Algorithms | 2 | 2011 | 668 | 0.110 |
Why?
| | Cooperative Behavior | 1 | 2017 | 233 | 0.110 |
Why?
| | Physicians, Women | 1 | 2015 | 20 | 0.110 |
Why?
| | Pain, Postoperative | 2 | 2018 | 169 | 0.110 |
Why?
| | Arkansas | 1 | 2021 | 2068 | 0.110 |
Why?
| | Awareness | 1 | 2014 | 26 | 0.110 |
Why?
| | Puerperal Infection | 1 | 2014 | 4 | 0.110 |
Why?
| | Middle Aged | 8 | 2026 | 13422 | 0.110 |
Why?
| | Odds Ratio | 3 | 2013 | 567 | 0.110 |
Why?
| | Embolism, Amniotic Fluid | 1 | 2014 | 1 | 0.100 |
Why?
| | Placenta Diseases | 1 | 2013 | 13 | 0.100 |
Why?
| | New York | 1 | 2013 | 52 | 0.100 |
Why?
| | Labor Stage, First | 1 | 2013 | 7 | 0.100 |
Why?
| | Injections, Spinal | 1 | 2013 | 22 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2014 | 153 | 0.100 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 92 | 0.100 |
Why?
| | Blood Coagulation Disorders | 1 | 2013 | 41 | 0.100 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 47 | 0.100 |
Why?
| | Adolescent | 6 | 2025 | 6912 | 0.100 |
Why?
| | Aged | 6 | 2026 | 10430 | 0.100 |
Why?
| | Obstetrics and Gynecology Department, Hospital | 1 | 2012 | 10 | 0.100 |
Why?
| | Patient Admission | 1 | 2013 | 81 | 0.090 |
Why?
| | Health Services Needs and Demand | 1 | 2014 | 163 | 0.090 |
Why?
| | Guidelines as Topic | 2 | 2013 | 111 | 0.090 |
Why?
| | Survival Analysis | 2 | 2013 | 659 | 0.090 |
Why?
| | Electrocardiography | 2 | 2013 | 272 | 0.090 |
Why?
| | Databases, Factual | 2 | 2018 | 742 | 0.090 |
Why?
| | Pregnancy, Multiple | 1 | 2012 | 18 | 0.090 |
Why?
| | Hematoma, Epidural, Spinal | 1 | 2012 | 2 | 0.090 |
Why?
| | Hemorrhage | 1 | 2014 | 226 | 0.090 |
Why?
| | Women | 1 | 2012 | 30 | 0.090 |
Why?
| | Metals | 1 | 2012 | 37 | 0.090 |
Why?
| | World Health Organization | 1 | 2012 | 59 | 0.090 |
Why?
| | Biomedical Research | 1 | 2015 | 267 | 0.090 |
Why?
| | Critical Illness | 1 | 2014 | 316 | 0.090 |
Why?
| | Intensive Care Units | 1 | 2013 | 243 | 0.090 |
Why?
| | Ticlopidine | 1 | 2012 | 71 | 0.090 |
Why?
| | Survival Rate | 1 | 2014 | 949 | 0.090 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2011 | 19 | 0.090 |
Why?
| | Heart Failure | 2 | 2014 | 531 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 502 | 0.080 |
Why?
| | Data Collection | 2 | 2014 | 288 | 0.080 |
Why?
| | Aspirin | 1 | 2012 | 123 | 0.080 |
Why?
| | Peptides | 1 | 2012 | 234 | 0.080 |
Why?
| | Hospitals, University | 1 | 2011 | 75 | 0.080 |
Why?
| | Ventricular Fibrillation | 1 | 2010 | 19 | 0.080 |
Why?
| | Organizational Policy | 1 | 2010 | 39 | 0.080 |
Why?
| | Blood Loss, Surgical | 1 | 2010 | 66 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 1367 | 0.080 |
Why?
| | Tachycardia, Ventricular | 1 | 2010 | 44 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2020 | 1221 | 0.070 |
Why?
| | Epidural Space | 1 | 2009 | 9 | 0.070 |
Why?
| | Polyurethanes | 1 | 2009 | 10 | 0.070 |
Why?
| | Needles | 1 | 2009 | 25 | 0.070 |
Why?
| | Canada | 1 | 2009 | 112 | 0.070 |
Why?
| | Prevalence | 4 | 2018 | 1034 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 56 | 0.070 |
Why?
| | Wounds, Penetrating | 1 | 2009 | 39 | 0.070 |
Why?
| | Blood Vessels | 1 | 2009 | 73 | 0.070 |
Why?
| | Psychometrics | 1 | 2010 | 244 | 0.070 |
Why?
| | Veins | 1 | 2009 | 74 | 0.070 |
Why?
| | Periodicals as Topic | 1 | 2009 | 63 | 0.070 |
Why?
| | Patient Satisfaction | 1 | 2010 | 292 | 0.070 |
Why?
| | Emergency Medicine | 1 | 2008 | 50 | 0.070 |
Why?
| | Medical Errors | 1 | 2007 | 21 | 0.060 |
Why?
| | Magnetic Resonance Angiography | 1 | 2007 | 72 | 0.060 |
Why?
| | Male | 7 | 2026 | 27444 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2012 | 501 | 0.060 |
Why?
| | Patient Positioning | 2 | 2018 | 31 | 0.060 |
Why?
| | Postoperative Care | 1 | 2007 | 109 | 0.060 |
Why?
| | Quality Improvement | 2 | 2018 | 230 | 0.060 |
Why?
| | Length of Stay | 3 | 2018 | 684 | 0.060 |
Why?
| | Neostigmine | 1 | 2025 | 4 | 0.060 |
Why?
| | Atracurium | 1 | 2025 | 4 | 0.060 |
Why?
| | Operating Rooms | 2 | 2016 | 27 | 0.060 |
Why?
| | Neuromuscular Blocking Agents | 1 | 2025 | 10 | 0.060 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2025 | 7 | 0.060 |
Why?
| | Glomerular Filtration Rate | 1 | 2025 | 128 | 0.050 |
Why?
| | Patient Education as Topic | 1 | 2007 | 325 | 0.050 |
Why?
| | Diagnosis, Differential | 1 | 2007 | 1038 | 0.050 |
Why?
| | Nursing Homes | 1 | 2003 | 110 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2003 | 199 | 0.040 |
Why?
| | Medicaid | 2 | 2013 | 294 | 0.040 |
Why?
| | Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 19 | 0.040 |
Why?
| | Family | 1 | 2020 | 179 | 0.040 |
Why?
| | Parturition | 1 | 2018 | 51 | 0.030 |
Why?
| | Advanced Cardiac Life Support | 1 | 2018 | 13 | 0.030 |
Why?
| | Women's Health | 1 | 2018 | 80 | 0.030 |
Why?
| | Cardiopulmonary Bypass | 1 | 2018 | 91 | 0.030 |
Why?
| | Health Personnel | 1 | 2020 | 259 | 0.030 |
Why?
| | Massachusetts | 1 | 2016 | 35 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 394 | 0.030 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2015 | 21 | 0.030 |
Why?
| | Cardiovascular Agents | 1 | 2015 | 66 | 0.030 |
Why?
| | Hypotension | 1 | 2015 | 62 | 0.030 |
Why?
| | Poisson Distribution | 1 | 2014 | 36 | 0.030 |
Why?
| | Uterine Rupture | 1 | 2014 | 10 | 0.030 |
Why?
| | Vascular Access Devices | 1 | 2014 | 23 | 0.030 |
Why?
| | Age Distribution | 1 | 2014 | 175 | 0.030 |
Why?
| | Disseminated Intravascular Coagulation | 1 | 2013 | 4 | 0.030 |
Why?
| | Resuscitation | 1 | 2014 | 72 | 0.020 |
Why?
| | Uterus | 1 | 2014 | 81 | 0.020 |
Why?
| | Pregnancy, Ectopic | 1 | 2013 | 7 | 0.020 |
Why?
| | Maryland | 1 | 2013 | 29 | 0.020 |
Why?
| | Liver Failure | 1 | 2013 | 21 | 0.020 |
Why?
| | Chlorzoxazone | 1 | 1993 | 5 | 0.020 |
Why?
| | Maternal Age | 1 | 2013 | 42 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2018 | 477 | 0.020 |
Why?
| | Abortion, Induced | 1 | 2013 | 20 | 0.020 |
Why?
| | Curriculum | 1 | 2016 | 409 | 0.020 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1993 | 32 | 0.020 |
Why?
| | Patients | 1 | 2013 | 52 | 0.020 |
Why?
| | Regression Analysis | 1 | 2014 | 391 | 0.020 |
Why?
| | Disulfiram | 1 | 1993 | 13 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2013 | 51 | 0.020 |
Why?
| | Forecasting | 1 | 2013 | 152 | 0.020 |
Why?
| | Survivors | 1 | 2013 | 120 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2014 | 598 | 0.020 |
Why?
| | Acute Disease | 1 | 2013 | 393 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2013 | 93 | 0.020 |
Why?
| | Pulmonary Embolism | 1 | 2013 | 83 | 0.020 |
Why?
| | Laminectomy | 1 | 2012 | 8 | 0.020 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1993 | 191 | 0.020 |
Why?
| | Respiration, Artificial | 1 | 2014 | 293 | 0.020 |
Why?
| | Obstetric Labor Complications | 1 | 2011 | 25 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2009 | 2318 | 0.020 |
Why?
| | Tooth Injuries | 1 | 2011 | 1 | 0.020 |
Why?
| | Laryngopharyngeal Reflux | 1 | 2011 | 2 | 0.020 |
Why?
| | Pneumothorax | 1 | 2011 | 20 | 0.020 |
Why?
| | Heart Diseases | 1 | 2013 | 221 | 0.020 |
Why?
| | Internet | 1 | 2012 | 265 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 2013 | 301 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2013 | 530 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 169 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2009 | 547 | 0.020 |
Why?
| | Models, Statistical | 1 | 2009 | 229 | 0.020 |
Why?
| | Research Design | 1 | 2009 | 373 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 869 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2012 | 3495 | 0.010 |
Why?
| | Long-Term Care | 1 | 2003 | 50 | 0.010 |
Why?
| | Dementia | 1 | 2003 | 141 | 0.010 |
Why?
| | Hydroxylation | 1 | 1993 | 64 | 0.010 |
Why?
| | Biotransformation | 1 | 1993 | 84 | 0.010 |
Why?
| | Drug Interactions | 1 | 1993 | 196 | 0.010 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 1993 | 111 | 0.010 |
Why?
| | Random Allocation | 1 | 1993 | 284 | 0.010 |
Why?
| | Down-Regulation | 1 | 1993 | 344 | 0.010 |
Why?
|
|
Mhyre's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|